EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Treatment‐Free Outcomes Following Surgery for IBD : A Nationwide Cohort Study

Adam S Faye iD, Jordan Axelrad iD, Jiangwei Sun iD, Jonas Halfvarsson, SWIBREG Study Group, Par Myrelid iD, Jonas Söderling, Ola Olén, Jonas F Ludvigsson iD

Alimentary Pharmacology & Therapeutics · 2026-03 · 63 (6) · 821-837

DOI: 10.1111/apt.70432 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 21.10.2025. Verfasst von Adam S Faye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, NYU School of Medicine, Inflammatory Bowel Disease Center at NYU Langone Health, New York, New …. Hauptthemen laut MEDLINE: Crohn Disease, Colitis, Ulcerative, Colectomy, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, National institute of aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Surgery in select individuals with inflammatory bowel disease (IBD) may obviate the need for future IBD‐related treatment.

Aims

To characterise individuals who remain treatment‐free during the first 5 years after initial IBD‐related surgery.

Methods

We performed a nationwide cohort study using the Swedish National Patient Register and the ESPRESSO histopathology to identify individuals undergoing first IBD‐related intestinal resection for Crohn's disease (CD) or total colectomy for ulcerative colitis (UC) between 2007 and 2018. We calculated adjusted odds ratios (aORs) for the need for any IBD‐related therapy within the first 5 years post surgery.

Results

We included 1709 individuals with CD and 1010 with UC. At 5 years, 21.5% with CD and 42.4% with UC remained ‘treatment free’. Being ‘treatment free’ 5 years after surgery was more common among patients with CD who had longer preoperative disease duration and older adults with UC. It was less common among individuals with extraintestinal manifestations of disease (CD aOR 0.64, 95% CI 0.43–0.97; UC aOR 0.48, 95% CI 0.31–0.73) and patients with CD who had chronic obstructive pulmonary disease.

Conclusions

Surgery obviated the need for future therapy in 22% of patients with CD and 42% with UC. Absence of extraintestinal manifestations, older age in UC, and longer disease duration and absence of chronic obstructive pulmonary disease in CD may highlight an opportunity for precision surgery to identify those most likely to achieve long‐term benefit from surgical intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseColitis, UlcerativeColectomyInflammatory Bowel DiseasesHumansFemaleMaleAdultMiddle AgedSwedenCohort StudiesTreatment OutcomeRegistriesAgedYoung AdultAdolescent

Stichwörter der Autor:innen

Crohn's diseaseinflammatory bowel diseasesurgeryulcerative colitis

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, NYU School of Medicine, Inflammatory Bowel Disease Center at NYU Langone Health, New York, New York, USA.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Department of Surgery, County Council of Östergötland and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Sachs' Children and Youth Hospital, Stockholm South General Hospital, Stockholm, Sweden.

ORCID-Profile: Adam S Faye, Jordan Axelrad, Jiangwei Sun, Par Myrelid, Jonas F Ludvigsson

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS
  • National institute of aging

Zitieren

APA

Faye, A. S., Axelrad, J., Sun, J., Halfvarsson, J., SWIBREG Study Group, Myrelid, P., Söderling, J., Olén, O., & Ludvigsson, J. F. (2026). Treatment‐Free Outcomes Following Surgery for IBD : A Nationwide Cohort Study. Alimentary Pharmacology & Therapeutics, 63(6), 821-837. https://doi.org/10.1111/apt.70432

Vancouver

Faye AS, Axelrad J, Sun J, Halfvarsson J, SWIBREG Study Group, Myrelid P, et al. Treatment‐Free Outcomes Following Surgery for IBD : A Nationwide Cohort Study. Alimentary Pharmacology & Therapeutics. 2026;63(6):821-837. doi:10.1111/apt.70432

BibTeX
@article{Faye2026,
  author = {Faye, Adam S and Axelrad, Jordan and Sun, Jiangwei and Halfvarsson, Jonas and SWIBREG Study Group, SWIBREG Study Group and Myrelid, Par and Söderling, Jonas and Olén, Ola and Ludvigsson, Jonas F},
  title = {Treatment‐Free Outcomes Following Surgery for IBD : A Nationwide Cohort Study},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {6},
  pages = {821--837},
  doi = {10.1111/apt.70432}
}
Kostenlos starten →